COLL vs FOX · P/E 17, rev $181.9M vs P/E 13, rev $16.30B
Collegium Pharmaceutical Inc (COLL) versus Fox Corp Class B (FOX) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Not investment advice. Open the COLL and FOX stock pages for the full models.
Not investment advice.